Showing 1 posts of 1 posts found.
The pharma industry is moving away from traditional in-house innovation and toward a more diversified business model, but will encounter …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO